Home » Program CXL Meeting 2024
Time | Title | Speakers | Country |
---|---|---|---|
9.30 – 10.00 | Coffee Break | ||
10.00 – 10.30 | Corneal structure and biomechanics | John Marshall | UK |
10.30 – 11.00 | Oxygen, riboflavin and UV-A. Understanding the CXL reaction | Farhad Hafezi | Switzerland |
11.00 – 11.30 | CXL: biomechanics, resistance to digestion, oxidative stress, endothelial safety | Theo G. Seiler | Switzerland |
11.30 – 12.00 | Pre -op assessment when and to to operate? | Paolo Vinciguerra | Italy |
12.00 – 12.30 | How to do my first CXL | Frederik Raiskup | Germany | 12.30 – 13.00 | Modifying riboflavin solutions and fluence, when to use which? | Cosimo Mazzotta | Italy |
13.00 – 14.00 | Lunch | ||
Time | Title | Speakers | Country |
---|---|---|---|
14.00 – 14.12 | To provide guidelines and best practices for screening low to non-compliant patients | Nikki Hafezi | Switzerland |
14.12 – 14.24 | To share best practice models and recruit investigators to enroll in the KMAP study | Emilio Torres | Switzerland |
14.24 – 14.36 | To demonstrate the need for partnerships | Nikki Hafezi | Switzerland |
14.36 – 14.48 | Best practice models of overall vision screening in children from economically-challenged areas | Mouhcine El Bakkali | Morocco |
14.48 – 15.00 | Questions & Answers |
Time | Title | Speakers | Country |
---|---|---|---|
15.00 – 15.20 | EMAGine’s new CXL protocols starting 2025 and an outlook into the immediate future. | Farhad Hafezi | Switzerland |
15.20 – 15.40 | ELZA-PACE and ELZA-STARK. Customized CXL for keratoconus and post RK. | Emilio Torres | Switzerland |
15.40 – 16.00 | ECO-CAIRS with the Ziemer Z8 and CSO’s MS-39: using extracorporeal ultra-high fluence in CAIRS. | Farhad Hafezi, Emilio Torres, Enes Aydemir | Switzerland |
16.00 – 16.15 | Coffee Break |
Time | Title | Speakers | Country |
---|---|---|---|
16.15 – 16.30 | SCHWIND Keratoconus Toolbox and Foresight | Andreas Krämer | Germany |
16.30 – 16.45 | Treatment procedure and 12-month clinical outcomes after customized treatments of Keratoconus | Dr. Robert Herber | Germany |
16.45 – 17.00 | Revolutionizing Corneal Surgery: CAIRS and Atos Integration | Dr. Juan Arbelaez | Oman |
17.00 – 17.12 | Questions and Answers |
Time | Title | Speakers | Country |
---|---|---|---|
17.30 – 17.42 | The Pentacam® Cornea OCT: A Novel Paradigm Shift in Corneal Imaging | Prof. Rohit Shetty | India |
17.42 – 17.54 | Pentacam® Cornea OCT and Corvis® ST – the triangle of Corneal management | Dr. Riccardo Vinciguerra | Italy |
17.54 – 18.06 | The Belin ABCD – for Keratoconus Staging and Progression – pre- and post CXL | Prof. Michael Belin | USA |
18.06 – 18.18 | In Vivo Corneal Stiffness Mapping based on Corvis ST and Pentacam | Dr. Robert Herber | Germany |
18.06 – 18.18 | Questions and Answers |
Time | Title | Speaker | Country |
---|---|---|---|
07:45 – 08.00 | Opening | Farhad Hafezi |
Time | Title | Speaker | Country |
---|---|---|---|
08:00 | Transepithelial Corneal Cross-Linking Advancement with Novel Hibiscus-Inspired RF/ZIF-8 Composites | Jinhai Huang | China |
08:08 | Efficacy and Safety of Oxygen-Enriched Rose Bengal and Green Light Corneal Cross-linking | Jinhai Huang | China |
08:16 | Delayed late onset of severe progressive corneal flattening – a complication 9 years after CXL | Giulia Firmani | UK |
08:24 | Discussion | ||
08:30 | Softest Point Analysis in Normal, Subclinical, and Keratoconic Corneas Using Motion tracking Brillouin Microscopy | J. Bradley Randleman | USA |
08:38 | 3D Analysis and Characterization of Normal, Subclinical, and KC Corneas Using Motion Tracking Brillouin Microscopy | J. Bradley Randleman | USA |
08:46 | A Futuristic Genetic Panel for Keratoconus in Early Detection and Shaping Next-Generation Therapies. | Shruti Kochar Maru | India |
08:54 | Discussion |
Time | Title | Speaker | Country |
---|---|---|---|
09:00 | Presentation of the Delphi Panel | Farhad Hafezi | Switzerland |
09:15 | First Results | José Álvaro Pereira Gomes | Brazil |
Time | Title | Speaker | Country |
---|---|---|---|
09:30 | Epi-off Protocols | Cosimo Mazzotta | Italy |
09:45 | Epi-on Protocols | Emilio Torres-Netto | Switzerland |
10:00 | Customized CXL | Farhad Hafezi | Switzerland |
10:15 | Complications and Surprises | Paolo Vinciguerra | Italy |
10:30 | Coffee Break |
Time | Title | Speaker | Country |
---|---|---|---|
11:00 | Corneal Topography and Tomography | J. Bradley Randleman | USA |
11:15 | A new index to detect keratoconus | Riccardo Vinciguerra | Italy |
11:30 | Scheimpflug technology | Michael Belin | USA |
11:45 | OCT technology | Shady Awwad | Lebanon |
12:00 | Scheimpflug vs OCT, CXL Success | Farhad Hafezi | Switzerland |
12:15 | Epithelium before and after CXL | Robert Herber | Germany |
12:45 | Lunch Break |
Time | Awardee |
---|---|
13:30 |
|
Time | Title | Speaker | Country |
---|---|---|---|
14:00 | DALK – Big bubble Technique. Why, When and How | Anas Anbari | UK |
14:15 | DALK complications: waking up from nightmares | José Alvaro Gomes | Brazil |
Time | Title | Speaker | Country |
---|---|---|---|
14:30 | KC and biomechanics I (CorVis & Brillouin) | Riccardo Vinciguerra | Italy |
14:45 | KC and biomechanics II (Brillouin) | J. Bradley Randleman | USA |
15:00 | KC and biomechanics III (OCT Elastography) | Sabine Kling | Switzerland |
15:15 | Biological markers in KC | Rohit Shetty | |
15:30 | Long-term flattening in KC and ectasia | Paolo Vinciguerra | Italy |
15:45 | Discussion | ||
16:00 | Coffee Break |
Time | Title | Speaker | Country |
---|---|---|---|
16:30 | IOL power calculations , choosing the right formula | Emilio Torres | Switzerland |
16:40 | Tips & Pearls in phacoemulsification in KC | Jorge Alió del Barrio | Spain |
16:50 | Pinhole vs monofocal IOLs | Riccardo Vinciguerra | Italy |
17:00 | Phakic IOLs in KC: optimizing outcomes | Shady Awwad | Lebanon |
17:10 | Sizing in Phakic IOLs | Andrea Russo | Italy |
17:20 | Refractive Surprise after Toric phakic IOLs: what to do | Jorge Alió | Spain |
Time | Title | Speaker | Country |
---|---|---|---|
17:30 | New insights into CXL-resistance to digestion | Farhad Hafezi | Switzerland |
17:40 | RF PACK-CXL for infectious keratitis | Boris Knyazer | Israel |
17:50 | RB PACK-CXL for infectious keratitis | Jaime Martinez | USA |
Time | Venue |
---|---|
19:00 | FIFA Museum, Seestrasse 27, 8002 Zurich, Switzerland |
Time | Title | Speaker | Country |
---|---|---|---|
08:00 | Measuring Biomechanical Changes of Collagen Cross-Linking with Rose Bengal and Green Light using AMF | Salomon Merikansky | USA |
08:10 | Rose Bengal PDAT/PACK-CXL for Acanthamoeba Keratitis: In Vitro Cysticidal Evaluation | Juan Carlos Navia | USA |
08:20 | Discussion | ||
08:30 | Graphitic Carbon Nitride Quantum Dots for Enhanced Corneal Cross-linking | Jinhai Huang | China |
08:40 | Precision Microneedle-Enhanced Riboflavin Delivery for Customized Corneal Cross-Linking in Keratoconus Therapy | Jinhai Huang | China |
08:50 | Discussion |
Time | Title | Speaker | Country |
---|---|---|---|
8:00 | Efficacy of KeraVio using Violet Light Emitting Glasses without Riboflavin Drops for Progressive Keratoconus [WITHDRAWN] | Hidenaga Kobashi | Japan |
8:05 | Megadose dietary riboflavin & sunlight in treatment of keratoconus & post-refractive ectasia – an update | John Jarstad | USA |
8:10 | Comparative Efficacy of Customized PRK/CXL Versus CXL Alone in the Management of Progressive KC | Jorge Alió del Barrio | Spain |
8:15 | Multicenter, randomized Sham-Controlled Phase 3 Study to evaluate epi-on CXL in KC subjects 8 to 45 years | Michael Belin | USA |
8:20 | Long-Term Graft Survival after Rose Bengal Photodynamic Antimicrobial Therapy for Infectious Keratitis and Keratoplasty | Jose Miguel Mora Correa | USA |
8:25 | Discussion | ||
8:30 | Macular choroidal thickness in keratoconus | Negates Yazdani | Iran, Islamic Republic of |
8:35 | The disappearing Cone | Bandana Sundaram | India |
8:40 | Evaluating Progression Thresholds in Varied Stages of Keratoconus: Precision in Corneal Epithelium Measurements for Predicting Disease Progression | Jinhai Huang | China |
8:45 | Evaluating the Global Consensus on Keratoconus and Ectatic Diseases Agreements on Subclinical Keratoconus | Bradley Randleman | USA |
8:50 | Discussion |
Time | Title | Speaker | Country |
---|---|---|---|
9:00 | Basics of Corneal Topography | Stephen Klyce | USA |
9:20 | Basics of Corneal Tomography | Michael Belin | USA |
09:40 | Basics of AS-OCT | Francesco Versaci | Italy |
10:00 | Basics of Corneal Biomechanics | Riccardo Vinciguerra | Italy |
10:30 – 11.00 | Coffee Break |
Time | Title | Speaker | Country |
---|---|---|---|
11:00 | Wavefront-guided surface ablation | Paolo Vinciguerra | Italy |
11:15 | ELZA-PACE: customized cross-linking | Farhad Hafezi | Switzerland |
11:30 | Discussion | ||
11:45 | Customized PRK and CXL: latest trends, do’s and don’ts | Paolo Vinciguerra | Italy |
12:00 | CAIRS | Soosan Jacob | India |
12:15 | Femto-CAIRS | Shady Awwad | Lebanon |
12:30 | ECO-CAIRS | Farhad Hafezi | Switzerland |
12:45 | Discussion | ||
13:00 | Femto-CAIRS: How to start | Jorge Alio del Barrio | Spain |
13:15 | CAIRS from the patient’s perspective | Wojciech Przybylski | Poland |
13:25 | Discussion | ||
13:30 | Lunch Break |
14:30 | Lenticule Augmentation | Mario Nubile | Italy |
14:45 | TREK | Rohit Shetty | India |
15:00 | Discussion | ||
15:15 | Bowman layer transplantation: evolving technique and results | Lamis Baydoun | Germany |
15:30 | ICRS: results and long-term safety | Olivier Prisant | France |
15:45 | Discussion | ||
16:00 | Group Photo | ||
16:15 | Coffee Break |
16:45 | Are we ready to transition from ICRS to CAIRS? | Shady Awwad | Lebanon |
17:15 | Xenia implants for Keratoconus: where do we stand? | Marwan Ghabra | |
17:30 | Discussion |
Time | Title | Speaker | Country |
---|---|---|---|
17:45 | A Review of Studies Evaluating Recurrent Keratoconus | Joseph Ciolino | USA |
17:50 | Can collagen imaging be a surrogate marker for KC genetics | Sannidhi BJ | India |
17:55 | Crosslinked All-Femtosecond Laser-Cut CAIRS (AFXL CAIRSs): Pilot Ex Vivo Study and Report of First Two Cases Performed in Italy | Marco Zagari | Italy |
18:00 | Medical Crosslinking And It’s Impact Ocular Surface For Stabilizing Keratoconus. | DrSanjri Malhotra | India |
18:05 | Discussion | ||
18:10 | Two-Year Results for Treating Keratoconus: Posterior Corneal Stromal Xenia Implant. The Ghabra Technique . | Marwan Ghabra | UK |
18:15 | Wound Signaling, Immunology, and Corneal Collagen Cross-Linking (CXL) Scars: A Biomarker Perspective | Abha Shah | India |
18:20 | “Ex Vivo Corneal Cross-Linking for Vascularized High-Risk Keratoplasty (ExCrossV)”: Outline of clinical trial background and design. | Joseph Ciolino | USA |
18:25 | Discussion |
Time | Title | Speaker | Country |
---|---|---|---|
08:00 | Crosslinking in children | Danuta Horodynska | Poland |
08:05 | I just did a cross-link in a 84 year old man | Asaf Achiron | Germany |
08:10 | Comparison Of Laser-Assisted Epithelium Removal With And Without Corneal Wavefront-Guided PRK Combined With CXL In Progressive KC | Robert Herber | Israel |
08:15 | Corneal Crosslinking for Children 13 years-old or younger | Naoko Kato | Japan |
08:20 | Biomechanical changes between KLEX refractive surgery with and without crosslinking (CXL) | Jiwon Jeong | Korea, Republic of |
08:25 | Discussion | ||
08:30 | Sleep apnea and the cornea | Jenny Borissova | Bulgaria |
08:35 | Assessment of corneal epithelium thickness using Heidelberg Anterion Swept-Source OCT in early keratoconus | Beata Sawicka-Wojtiuk | Poland |
08:40 | Effects of Lotrafilcon A and Senofilcon A bandage contact lenses on visual rehabilitation and ocular discomfort after photorefractive keratectomy | Konuralp Yakar | Turkey |
08:45 | CXL+PRK vs. CXL alone for progressive keratoconus: meta-analysis | Asaf Achiron | Israel |
08:50 | Corneal Biomechanical Properties Measured with Brillouin Scanning | Anders Behndig | Sweden |
08:55 | Three-year follow-up of Accelerated versus Accelerated Contact Lens–Assisted CXL for Progressive Keratoconus in Adults | Anna Bunin | Israel |
09:00 | Discussion |
Copyright 2024, CXL Experts' Meeting. All Rights Reserved.